Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
24 hedge funds and large institutions have $38.7M invested in Global Cord Blood Corporation in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 6 closing their positions.
224% more call options, than puts
Call options by funds: $253K | Put options by funds: $78K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
12% more capital invested
Capital invested by funds: $34.7M → $38.7M (+$4.02M)
4% less funds holding
Funds holding: 25 → 24 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$5M |
| 2 |
Man Group
London,
United Kingdom
|
+$4.43M |
| 3 |
ICM
ISZO Capital Management
New York
|
+$687K |
| 4 |
BFEC
Benjamin F. Edwards & Company
St. Louis,
Missouri
|
+$145K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$1.73M |
| 2 |
Renaissance Technologies
New York
|
-$485K |
| 3 |
FCM
FourWorld Capital Management
New York
|
-$337K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$135K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$56.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Arrowstreet Capital
Boston,
Massachusetts
| – | -$37K | -12,486 | Closed |
|
|
SPIA
27
Steward Partners Investment Advisory
New York
| – | -$7.96K | -3,239 | -96% |
|
|
NFSG
28
Newbridge Financial Services Group
Boca Raton,
Florida
| – | -$8K | -2,565 | Closed |
|
29
Group One Trading
Chicago,
Illinois
| – | -$4.92K | -2,000 | Closed |
|
CO Hedge Fund Activity: Q3 2022 in Review
24 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q3 2022, worth a combined $38.7M — up 12% from $34.7M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CO and 5 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 5 added.
The largest buyer was Oasis Management Company, adding an estimated $5M. The largest seller was BlueCrest Capital Management, cutting an estimated $1.73M.
- 24 institutional investors held Global Cord Blood Corporation (CO) as of Q3 2022, down from 25 in Q2 2022.
- Funds reported $38.7M of Global Cord Blood Corporation stock for Q3 2022, up 12% quarter-over-quarter.
- 5 funds opened new Global Cord Blood Corporation positions in Q3 2022 and 6 closed out, a net change of -1 holder.
- The largest Global Cord Blood Corporation buyer in Q3 2022 was Oasis Management Company, an estimated $5M added.
- The largest Global Cord Blood Corporation seller in Q3 2022 was BlueCrest Capital Management, an estimated $1.73M sold.
Based on aggregated 13F filings for Q3 2022.